Showing results (601-610 of 635) with videos related to
Sort By:
Pageof 64
Nature Metabolism|February 4, 2021
SARS-CoV-2 infects and replicates in cells of the human endocrine and exocrine pancreasJanis A Müller, Rüdiger Groß, Carina Conzelmann, et al.European Journal of Cancer (Oxford, England : 1990)|May 22, 2022
The impact of TP53 co-mutations and immunologic microenvironment on outcome of lung cancer with EGFR exon 20 insertionsPetros Christopoulos, Klaus Kluck, Martina Kirchner, et al.Med (New York, N.Y.)|May 1, 2026
Clinically actionable genomic and transcriptomic landscape of advanced neuroendocrine neoplasmsSimon Kreutzfeldt, Leonidas Apostolidis, Małgorzata Oleś, et al.Virchows Archiv : an International Journal of Pathology|February 29, 2012
Decentral gene expression analysis for ER+/Her2- breast cancer: results of a proficiency testing program for the EndoPredict assayCarsten Denkert, Ralf Kronenwett, Werner Schlake, et al.Nature Communications|April 11, 2019
Defective homologous recombination DNA repair as therapeutic target in advanced chordomaStefan Gröschel, Daniel Hübschmann, Francesco Raimondi, et al.Acta Neuropathologica|January 17, 2026
Germline variants in ATM, BRCA2, other cancer predisposition and novel candidate genes are implicated in glioma risk in adult glioma patients with a familial or personal history of tumorsFrank Brand, Lily S Rose, Amir H Akbarzadeh, et al.Hepatology (Baltimore, Md.)|January 12, 2020
Genomic Characterization of Cholangiocarcinoma in Primary Sclerosing Cholangitis Reveals Therapeutic OpportunitiesBenjamin Goeppert, Trine Folseraas, Stephanie Roessler, et al.Cancer Discovery|May 27, 2018
NRG1 Fusions in KRAS Wild-Type Pancreatic CancerChristoph Heining, Peter Horak, Sebastian Uhrig, et al.Clinical & Experimental Metastasis|July 23, 2025
Reconsidering palliative radiotherapy in addition to PD-1 blockade for non-small cell lung cancer: results from the FORCE phase II trial (AIO/YMO-TRK-0415)Farastuk Bozorgmehr, Inn Chung, Jürgen R Fischer, et al.Acta Neuropathologica|August 11, 2020
Infratentorial IDH-mutant astrocytoma is a distinct subtypeRouzbeh Banan, Damian Stichel, Anja Bleck, et al.Pageof 64